Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel To Monitor Treatment Journey for Patients With Traumatic Brain Injury and Alzheimer’s
UF Innovate's funding institution Gryphon Bio, Inc. is pursuing observational clinical studies with U.S. and international partners to validate a novel blood biomarker panel for early detection and monitoring of TBI and Alzheimer’s disease.